Genetic predisposition to ductal carcinoma in situ of the breast
Christos Petridis(National Health Service), Jan Lubiński(Tumour Institute of Tuscany), Minouk J. Schoemaker(Institute of Cancer Research), Volker Arndt(German Cancer Research Center), Angela Cox, Hiltrud Brauch(German Cancer Research Center), Natalia Bogdanova(Medizinische Hochschule Hannover), Thomas Brüning(Institute for Prevention and Occupational Medicine), Peter A. Fasching(Universitätsklinikum Erlangen), Daniel C. Tessier(McGill University and Génome Québec Innovation Centre), Jingmei Li(Genome Institute of Singapore), Graham G. Giles(The University of Melbourne), Annika Lindblom(Karolinska University Hospital), Simon S. Cross(University of Sheffield), Thilo Dörk(Hannover Re (Germany)), Jonine D. Figueroa, Michele Caneppele(Queen Mary University of London), Anthony J. Swerdlow(Institute of Cancer Research), Joe Dennis(University of Cambridge), Katri Pylkäs(University of Oulu), Anna González‐Neira(Spanish National Cancer Research Centre), Roger L. Milne(The University of Melbourne), Robert Winqvist(Oulu University Hospital), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Mark N. Brook(Institute of Cancer Research), Javier Benı́tez(Spanish National Cancer Research Centre), Jacques Simard(Université Laval), Dina Levi(Guy's Hospital), Ute Hamann(German Cancer Research Center), Nick Orr(United States Department of Health and Human Services), Hermann Brenner(Universidad de Granada), Efterpi Papouli(King's College London), Melissa C. Southey(The University of Melbourne), Patricia Gorman(The Honourable Society of Lincoln's Inn), Qin Wang(University of Cambridge), Daniel Vincent(The Netherlands Cancer Institute), Matthias W. Beckmann, Anne‐Lise Børresen‐Dale(Oslo University Hospital), John L. Hopper(The University of Melbourne), Vessela Kristensen(Roche (Switzerland)), Penny Soucy(University of Cambridge), Rita K. Schmutzler(The University of Melbourne), Vandna Shah(Guy's Hospital), Julian Peto(University of Helsinki), Manjeet K. Bolla(University of Cambridge), Alfons Meindl(Helmholtz Zentrum München), Maria Kabisch(German Cancer Research Center), Sara Margolin(University of Copenhagen), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine)
Cited by 64
Related Papers
Signatures of mutational processes in human cancer
|Nature|2013|10.1k
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-years for 32 Cancer Groups, 1990 to 2015
|JAMA Oncology|2016|6.3k
Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019
|The Lancet Public Health|2022|5.4k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k